Literature DB >> 12706985

Solving staphylococcal resistance to beta-lactams.

Henry F Chambers1.   

Abstract

Class resistance to beta-lactam antibiotics in Gram-positive bacteria is mediated by structural changes in transpeptidase penicillin-binding proteins. These structural changes render a complex series of interactions between antibiotic and protein that are energetically unfavorable, such that the active site is inactivated not at all or too slowly to prevent cell-wall synthesis and bacterial growth. Determination of the crystal structure of the low-affinity penicillin-binding protein PBP2a, which mediates beta-lactam antibiotic resistance in staphylococci, has identified the molecular structures and interactions that are responsible for resistance. This information could be useful for designing beta-lactams to overcome these structural impediments, as well as resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706985     DOI: 10.1016/s0966-842x(03)00046-5

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  9 in total

Review 1.  The bacterial cell envelope.

Authors:  Thomas J Silhavy; Daniel Kahne; Suzanne Walker
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-14       Impact factor: 10.005

2.  Discrete steps in sensing of beta-lactam antibiotics by the BlaR1 protein of the methicillin-resistant Staphylococcus aureus bacterium.

Authors:  Kanjana Thumanu; Jooyoung Cha; Jed F Fisher; Richard Perrins; Shahriar Mobashery; Christopher Wharton
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-30       Impact factor: 11.205

3.  Structural insights into the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of ceftobiprole.

Authors:  Andrew L Lovering; Michael C Gretes; Susan S Safadi; Franck Danel; Liza de Castro; Malcolm G P Page; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

4.  Potent in vitro activity of tomopenem (CS-023) against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Tetsufumi Koga; Nobuhisa Masuda; Masayo Kakuta; Eiko Namba; Chika Sugihara; Takashi Fukuoka
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

5.  PBP 2a mutations producing very-high-level resistance to beta-lactams.

Authors:  Yuki Katayama; Hong-Zhong Zhang; Henry F Chambers
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

6.  Gene acquisition at the insertion site for SCCmec, the genomic island conferring methicillin resistance in Staphylococcus aureus.

Authors:  Michael J Noto; Barry N Kreiswirth; Alastair B Monk; Gordon L Archer
Journal:  J Bacteriol       Date:  2007-12-14       Impact factor: 3.490

7.  Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones.

Authors:  Astrid Zervosen; Wei-Ping Lu; Zhouliang Chen; Ronald E White; Thomas P Demuth; Jean-Marie Frère
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

8.  Cefotaxime Mediated Synthesis of Gold Nanoparticles: Characterization and Antibacterial Activity.

Authors:  Turki Al Hagbani; Syed Mohd Danish Rizvi; Talib Hussain; Khalid Mehmood; Zeeshan Rafi; Afrasim Moin; Amr Selim Abu Lila; Farhan Alshammari; El-Sayed Khafagy; Mohamed Rahamathulla; Marwa H Abdallah
Journal:  Polymers (Basel)       Date:  2022-02-16       Impact factor: 4.329

Review 9.  Staphylococcus aureus, Antibiotic Resistance, and the Interaction with Human Neutrophils.

Authors:  Viktoria Rungelrath; Frank R DeLeo
Journal:  Antioxid Redox Signal       Date:  2020-06-23       Impact factor: 8.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.